Maharashtra FDA Asks Centre to Bring Essential Medical Devices Under Price Control After Finding Huge Discrepancies

Summary

Maharashtra's Food and Drug Administration (FDA) has identified significant price discrepancies for hospital medical devices, with procurement costs being much lower than declared MRPs. The agency has urged the central government to intervene and bring essential medical devices under price control to address regulatory gaps and potential increases in patient healthcare expenditure.